Therapy for sickle cell vaso-occlusive crises. Controlled clinical trials and cooperative study of intravenously administered alkali. Cooperative urea trials group.
D000468:Alkalies / Q000008:administration & dosage / Q000627:therapeutic use; D000755:Anemia, Sickle Cell / Q000150:complications / Q000188:drug therapy*; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D005947:Glucose / Q000627:therapeutic use; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007258:Informed Consent; D007275:Injections, Intravenous; D007773:Lactates / Q000627:therapeutic use; D008297:Male; D012075:Remission, Spontaneous; D012965:Sodium Chloride / Q000627:therapeutic use; D012996:Solutions; D013997:Time Factors
D000468:Alkalies; D007773:Lactates; D012996:Solutions; D012965:Sodium Chloride; D005947:Glucose